TrialJAMA oncology2017

Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial.

Elizabeth L Barry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.